» Articles » PMID: 34342266

Role of Direct and Indirect Social and Spatial Ties in the Diffusion of HIV and HCV Among People Who Inject Drugs: a Cross-sectional Community-based Network Analysis in New Delhi, India

Abstract

Background: People who inject drugs (PWID) account for some of the most explosive human immunodeficiency virus (HIV) and hepatitis C virus (HCV) epidemics globally. While individual drivers of infection are well understood, less is known about network factors, with minimal data beyond direct ties.

Methods: 2512 PWID in New Delhi, India were recruited in 2017-19 using a sociometric network design. Sampling was initiated with 10 indexes who recruited named injection partners (people who they injected with in the prior month). Each recruit then recruited their named injection partners following the same process with cross-network linkages established by biometric data. Participants responded to a survey, including information on injection venues, and provided a blood sample. Factors associated with HIV/HCV infection were identified using logistic regression.

Results: The median age was 26; 99% were male. Baseline HIV prevalence was 37.0% and 46.8% were actively infected with HCV (HCV RNA positive). The odds of prevalent HIV and active HCV infection decreased with each additional degree of separation from an infected alter (HIV AOR: 0.87; HCV AOR: 0.90) and increased among those who injected at a specific venue (HIV AOR: 1.50; HCV AOR: 1.69) independent of individual-level factors (p<0.001). In addition, sociometric factors, for example, network distance to an infected alter, were statistically significant predictors even when considering immediate egocentric ties.

Conclusions: These data demonstrate an extremely high burden of HIV and HCV infection and a highly interconnected injection and spatial network structure. Incorporating network and spatial data into the design/implementation of interventions may help interrupt transmission while improving efficiency.

Funding: National Institute on Drug Abuse and the Johns Hopkins University Center for AIDS Research.

Citing Articles

Network-based strategies to combat HCV: Examining social and spatial drivers of transmission among PWID in New Delhi.

Clipman S, Mehta S, Mohapatra S, Srikrishnan A, Zook K, Kumar M J Viral Hepat. 2024; 31(9):535-543.

PMID: 38837275 PMC: 11480898. DOI: 10.1111/jvh.13960.


Injection network drivers of HIV prevention service utilization among people who inject drugs: results of a community-based sociometric network cohort in New Delhi, India.

Prata Menezes N, Mehta S, Wesolowski A, Clipman S, Srikrishnan A, Kumar M J Int AIDS Soc. 2024; 27(4):e26241.

PMID: 38632848 PMC: 11024448. DOI: 10.1002/jia2.26241.


HIV, hepatitis B & C in people who inject drugs in India: A systematic review of regional heterogeneity & overview of opioid substitution treatment.

Shukla L, Shivaprakash P, Suresh Kumar M Indian J Med Res. 2024; 158(5&6):522-534.

PMID: 38265946 PMC: 10878493. DOI: 10.4103/ijmr.ijmr_1930_23.


Network centrality and HIV prevention service use among people who inject drugs: Findings from a sociometric network cohort in New Delhi, India.

Prata Menezes N, Mehta S, Wesolowski A, Clipman S, Srikrishnan A, Kumar M Addiction. 2023; 119(3):570-581.

PMID: 37967827 PMC: 11003398. DOI: 10.1111/add.16379.


The burden of hepatitis C virus in the world, China, India, and the United States from 1990 to 2019.

Yang J, Qi J, Wang X, Li X, Jin R, Liu B Front Public Health. 2023; 11:1041201.

PMID: 36935711 PMC: 10018168. DOI: 10.3389/fpubh.2023.1041201.


References
1.
Rudolph A, Young A, Havens J . Examining the Social Context of Injection Drug Use: Social Proximity to Persons Who Inject Drugs Versus Geographic Proximity to Persons Who Inject Drugs. Am J Epidemiol. 2017; 186(8):970-978. PMC: 6075186. DOI: 10.1093/aje/kwx162. View

2.
Kimani S, Watt M, Merli M, Skinner D, Myers B, Pieterse D . Respondent driven sampling is an effective method for engaging methamphetamine users in HIV prevention research in South Africa. Drug Alcohol Depend. 2014; 143:134-40. PMC: 4161639. DOI: 10.1016/j.drugalcdep.2014.07.018. View

3.
Friedman S, Neaigus A, Jose B, Curtis R, Goldstein M, Ildefonso G . Sociometric risk networks and risk for HIV infection. Am J Public Health. 1997; 87(8):1289-96. PMC: 1381088. DOI: 10.2105/ajph.87.8.1289. View

4.
Costenbader E, Astone N, Latkin C . The dynamics of injection drug users' personal networks and HIV risk behaviors. Addiction. 2006; 101(7):1003-13. DOI: 10.1111/j.1360-0443.2006.01431.x. View

5.
Solomon S, Boon D, Saravanan S, Srikrishnan A, Vasudevan C, Balakrishnan P . Diversity of hepatitis C virus infection among HIV-infected people who inject drugs in India. Virusdisease. 2020; 30(4):490-497. PMC: 6917681. DOI: 10.1007/s13337-019-00553-2. View